Efficacy of aspirin has not been fully utilized / map – aspirin and heart disease – the pharmaceutical industries
August 31, held in Barcelona, Spain, 2009 European Society of Cardiology (ESC2009) published a study on the data confirm that prevention of cardiovascular disease (CVD) is not the traditional full use of commonly used drugs aspirin, This will lead to serious health and economic consequences. Panel discussion from the underutilization of aspirin treatment of CVD and compliance research (ACT) the latest results and other recent low-dose aspirin on CVD prevention research, stressed the need to further expand the scope of aspirin therapy to help alleviate the cause of the global CVD mortality and morbidity burden.
HC Pharmacy Industrial network with map
Cardiovascular disease, especially coronary heart disease and stroke are the three major causes of death worldwide, one million deaths each year result in 1700, and the number of people at risk is increasing. World Heart Federation forecasts the number of deaths from cardiovascular disease by 2030 will increase to 2420 million, of which 80% will occur in low and middle income countries such as Russia, Brazil and China.
ACT is a European, Asia Pacific and South America and 18 countries, 7363 online survey of doctors found that, although more than 85% of patients with history of heart disease is recommended to use low-dose aspirin, However, the compliance of patients is still not ideal. Part of the problem caused by the doctors and the lack of regular contact between patients, the situation in South America, Europe and Asia Pacific the proportion was 45%, 65% and 72%.
However, even if patients go to the doctor, there is no guarantee that low-dose aspirin therapy can benefit patients in full compliance with medical advice to medication. ACT one of the researchers, Italy AugustoZaninelli professor said: "Even those who were followed up with the good relations between doctors for patients, their use of aspirin therapy compliance is not satisfactory. Our analysis this is because doctors and patients did not low-dose aspirin therapy for full discussion of this result to allow patients to fully participate in the decision process is to improve prescription compliance, a key measure. "In the ACT, the poor compliance of patients (including full and partial non-compliance compliance) in Europe, South America and Asia-Pacific share of 29%, 35% and 37%.
As in all anti-platelet drugs, the daily use of aspirin is the lowest cost, so price is not the main reason for their poor compliance. Belgium, Ghent University, Professor of Health Economics and drug epidemiology LievenAnnemans stressed that the recent economic analysis again confirmed the low-dose aspirin has a good cost-effective, even in those with lower risk of cardiovascular events occurred in the crowd the same is true. An analysis showed that patients with low-dose aspirin can reduce the cost of 10 years, for the United Kingdom can save 201 euros per patient, while the savings per patient in Spain up to 797 euros. "Even for those in the 10 years lower risk of cardiovascular disease in patients with low-dose aspirin therapy is also a cost saving measure." Annemans he added. University of Rochester School of Medicine ThomasPearson
professor said: "The new data confirmed the economic benefits of low-dose aspirin, but also highlighted the increase in those who benefit from the treatment of patients with the need to improve compliance. More full use of aspirin to help prevent the world each year a large number of cases of heart disease and stroke. In general, low-dose aspirin is indeed a kind of presence should be recommended for patients with risk of heart disease and stroke drug. "
World Heart Federation President ShahryarSheikh professor said: "Although we have such as aspirin effective preventive measures, if they can not make full use of the words, the global burden of cardiovascular disease will continue to increase." This will be the global significant impact on the economy, including the cost of the health care system and cardiovascular patients and their caregivers to reduce the loss of the ability to work the value of the income and production.
Based on a wealth of evidence-based medical data, international guidelines recommend the use of low-dose aspirin to reduce cardiovascular events and recurrence of starting. Professor Pearson stressed the need for the benefits of aspirin in patients with more Education Improve the guidelines recommended by doctors awareness, to increase the low-dose aspirin use in appropriate patients, thus reducing the burden of cardiovascular disease and improve health care systems to ensure national academic institutions to develop recommendations for treatment can be a good implementation.
I am a professional editor from Hardware Wholesale,
and my work is to promote a free online trade platform.
http://www.hardware-wholesale.com/ contain a great deal of information about
electric rebar cutter , electric paint rollers
welcome to visit!
Processing your request, Please wait....
